Last week I met with Paul Richardson and his fellow, Tom Garcia, to discuss my options for Revlimid maintenance going forward. This is the first time I had met Tom, who has worked with Paul for the last 3 years. He was very impressed with how well I am doing. One area I discussed with Paul was whether an MRD test would be clinically useful in determining whether or not I should remain on